Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Microbiotica raises £36M ($48M) in Series C to advance pipeline into Phase 2 clinical development.
Amount Raised
$48 Million
Round Type
Series C
CambridgeBiotechnologyHealth CareInvestors
Description
Microbiotica has secured £36 million ($48 million) in Series C financing to accelerate its drug development pipeline into Phase 2 clinical trials. The funding will support the company's efforts to advance its therapeutic candidates through further clinical development stages. This Series C round represents a significant milestone in Microbiotica's journey to bring its pipeline programs to market.
Fundz sees it the moment Microbiotica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Microbiotica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.